Live feed07:34:42·665dANALYSTRatingvia QuantisnowNeurocrine Biosciences upgraded by Piper Sandler with a new price targetByQuantisnow·Wall Street's wire, on your screen.NBIX· Neurocrine Biosciences Inc.Health CareOriginal source